Medinter Ltd

General

Total Cases1
Active Cases1
Patents--
TypeOperating Company
Elite Ratings
--
--
--
--

Ratings

Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
09/01/23
Letter to The Honorable Joshua D. Wolson from Zachary J. Schnapp regarding the Court's Order dated August 24, 2023. - re 461 Redacted Document, 460 Redacted Document, 459 Order,,. (Schnapp, Zachary) (Entered: 09/01/2023)
09/01/23
Letter to The Honorable Joshua D. Wolson from Zachary J. Schnapp regarding the Court's Order dated August 24, 2023. - re 461 Redacted Document, 460 Redacted Document, 459 Order,,. (Schnapp, Zachary) (Entered: 09/01/2023)
09/01/23
Letter to The Honorable Joshua D. Wolson from Zachary J. Schnapp regarding the Court's Order dated August 24, 2023. - re 461 Redacted Document, 460 Redacted Document, 459 Order,,. (Schnapp, Zachary) (Entered: 09/01/2023)
09/01/23
REDACTED VERSION of 452 Reply Brief, by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) (Entered: 09/01/2023)
09/01/23
REDACTED VERSION of 452 Reply Brief, by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) (Entered: 09/01/2023)
09/01/23
REDACTED VERSION of 452 Reply Brief, by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) (Entered: 09/01/2023)
09/01/23
REDACTED VERSION of 446 Opening Brief in Support, by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # 1 Ex. A, # 2 Ex. B, # 3 Ex. C)(Flynn, Michael) (Entered: 09/01/2023)
09/01/23
REDACTED VERSION of 446 Opening Brief in Support, by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # 1 Ex. A, # 2 Ex. B, # 3 Ex. C)(Flynn, Michael) (Entered: 09/01/2023)
09/01/23
REDACTED VERSION of 446 Opening Brief in Support, by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # 1 Ex. A, # 2 Ex. B, # 3 Ex. C)(Flynn, Michael) (Entered: 09/01/2023)
08/28/23
ORDER, Galderma's Motion For Default Judgment (D.I. 445 ) is DENIED WITHOUT PREJUDICE pending final resolution of the claims against the Individual Defendants. The Parties' Joint Motion To Seal (D.I. 457 ) is GRANTED IN PART and DENIED IN PART as follows: The Motion is GRANTED as to Galderma's proposed redactions; the Motion is DENIED as to the Individual Defendants' proposed redactions. The Parties' Joint Motion To Seal Their Motion To Seal (D.I. 458 ) is GRANTED IN PART and DENIED IN PART to the same extent as their Motion To Seal. On or before September 1, 2023, the Individual Defendants shall file unredacted versions of any materials for which I have denied leave to file under seal. (See Order for further details). Signed by Judge Joshua D. Wolson on 8/28/2023. (twk) (Entered: 08/28/2023)